Bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus Interactions
There are 353 drugs known to interact with bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus, along with 1 disease interaction. Of the total drug interactions, 353 are moderate.
- View all 353 medications that may interact with bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus
- View bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus disease interactions (1)
Most frequently checked interactions
View interaction reports for bifidobacterium infantis / bifidobacterium lactis / streptococcus thermophilus and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Acerola C (ascorbic acid)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Advil (ibuprofen)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Claritin (loratadine)
- CoQ10 (ubiquinone)
- Curcumin 95 (turmeric)
- Emergen-C (multivitamin with minerals)
- Flonase (fluticasone nasal)
- Imodium (loperamide)
- Iron Sulfate (ferrous sulfate)
- Lexapro (escitalopram)
- Macrobid (nitrofurantoin)
- Melatonin Time Release (melatonin)
- MiraLAX (polyethylene glycol 3350)
- Monurol (fosfomycin)
- Paxlovid (nirmatrelvir / ritonavir)
- Prilosec OTC (omeprazole)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Tums Ultra 1000 (calcium carbonate)
- Tylenol (acetaminophen)
- Ubrelvy (ubrogepant)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Zinc (zinc sulfate)
- Zyrtec (cetirizine)
Bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus disease interactions
There is 1 disease interaction with bifidobacterium infantis / bifidobacterium lactis / streptococcus thermophilus which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.